lansoprazole has been researched along with Ischemia in 2 studies
Lansoprazole: A 2,2,2-trifluoroethoxypyridyl derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS. Lansoprazole is a racemic mixture of (R)- and (S)-isomers.
Ischemia: A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION.
Excerpt | Relevance | Reference |
---|---|---|
"Lansoprazole inhibits lipid peroxidation and reduces development of intestinal mucosal inflammation induced by I/R in rats, suggesting that lansoprazole may have a therapeutic potential for I/R injury." | 7.72 | Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats. ( Ichikawa, H; Isozaki, Y; Katada, K; Naito, Y; Okanoue, T; Takagi, T; Tomatsuri, N; Uchiyama, K; Yoshida, N; Yoshikawa, T, 2004) |
"Lansoprazole inhibits lipid peroxidation and reduces development of intestinal mucosal inflammation induced by I/R in rats, suggesting that lansoprazole may have a therapeutic potential for I/R injury." | 3.72 | Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats. ( Ichikawa, H; Isozaki, Y; Katada, K; Naito, Y; Okanoue, T; Takagi, T; Tomatsuri, N; Uchiyama, K; Yoshida, N; Yoshikawa, T, 2004) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ichikawa, H | 1 |
Yoshida, N | 1 |
Takagi, T | 1 |
Tomatsuri, N | 1 |
Katada, K | 1 |
Isozaki, Y | 1 |
Uchiyama, K | 1 |
Naito, Y | 1 |
Okanoue, T | 1 |
Yoshikawa, T | 1 |
Schönhöfer, PS | 1 |
2 other studies available for lansoprazole and Ischemia
Article | Year |
---|---|
Lansoprazole ameliorates intestinal mucosal damage induced by ischemia-reperfusion in rats.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Gastrointestinal Agents; Inflammation; Intestinal | 2004 |
Safety of omeprazole and lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Anti-Ulcer Agents; Humans; Ischemia; Lansoprazole; Male; Mi | 1994 |